Clinical Trials

360 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07292272 2026-03-23

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study

LymphoidOther hematologic neoplasmPlasma cell

180 enrolled

Hodgkin Disease, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT07101328 2026-03-20

BAF_FRontier-1

215 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT07478848 2026-03-18

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

14 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07454863 2026-03-06

A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)

6 enrolled

Phase NA Not yet recruiting

Lymphoma, Non-Hodgkin

NCT07366450 2026-01-26

High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma

52 enrolled

Vitamin D Hydroxylation-Deficient Rickets, Type 1B, Lymphoma, Non-Hodgkin, Vitamin D Deficiency

NCT07166549 2025-12-24

BaseCAR-01

12 enrolled

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07225439 2025-11-06

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

15 enrolled

Phase 1/2 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07159906 2025-09-08

Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

62 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT05779930 2025-08-15

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

12 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07003178 2025-06-04

A Study to Evaluate the Safety and Clinical Efficacy of STR-P004

30 enrolled

Lymphoma, Non-Hodgkin

NCT06890091 2025-03-21

CAR-TIGUE

100 enrolled

Phase 1/2 Not yet recruiting

Fatigue, Lymphoma, Non-Hodgkin

NCT06845241 2025-02-25

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

68 enrolled

Phase NA Not yet recruiting

Lymphoma, Non-Hodgkin, Recurrence

NCT05416554 2025-02-11

Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford

20 enrolled

Phase 4 Not yet recruiting

Lymphoma, Non-Hodgkin

NCT06665737 2025-01-28

G-CSF in NHL

126 enrolled

Classical hematologyLymphoid

Lymphoma, Non-Hodgkin, Febrile Neutropenia

NCT06720701 2024-12-06

CLIO

125 enrolled

Lymphoma, Non-Hodgkin

NCT06721598 2024-12-06

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

60 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06646211 2024-10-17

High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

30 enrolled

Lymphoma, Non-Hodgkin

NCT06573099 2024-08-27

A Real-World Study on Extranodal Lymphoma

5,000 enrolled

Phase 3 Not yet recruiting

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06510530 2024-07-19

Astragalus for Symptomatic Alleviation in High-grade Lymphoma

60 enrolled

Lymphoma, Non-Hodgkin

NCT06427213 2024-05-23

This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma

41 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT06318884 2024-03-22

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

76 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Non-Hodgkin

NCT06097455 2023-10-26

CARTD-BG-1

40 enrolled

Lymphoma, Non-Hodgkin

NCT05923502 2023-10-23

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

200 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone

NCT05834426 2023-06-22

Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

50 enrolled

Lymphoma, Non-Hodgkin, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03969693 2023-04-18

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

50 enrolled

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Cardiotoxicity

NCT05746858 2023-02-28

MIMOSA

300 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT05381181 2023-01-27

Safety and Efficacy Evaluation of Next-generation CD19-UCART

20 enrolled

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02497898 2015-07-15

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

1,000 enrolled